Aurobindo Pharma announced its subsidiary Lannett Company LLC’s facility inspection concluded. The US Food and Drug Administration conducted this routine inspection from August 17-21, 2026. Four procedural observations were noted during the Seymour, USA facility’s review. The company will provide its response to the USFDA within the required timeframe.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.